Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Gerdts

Showing results (171-180 of 262) with videos related to

Pageof 27
Sort By:
Journal of Hypertension|March 27, 2003
Pulse pressure/stroke index and left ventricular geometry and function: the LIFE StudyVittorio Palmieri, Jonathan N Bella, Mary J Roman, et al.
The American Journal of Cardiology|June 1, 2011
Differences in cardiovascular risk profile between electrocardiographic hypertrophy versus strain in asymptomatic patients with aortic stenosis (from SEAS data)Anders M Greve, Eva Gerdts, Kurt Boman, et al.
Circulation. Cardiovascular Imaging|April 12, 2014
Four-group classification of left ventricular hypertrophy based on ventricular concentricity and dilatation identifies a low-risk subset of eccentric hypertrophy in hypertensive patientsCasper N Bang, Eva Gerdts, Gerard P Aurigemma, et al.
The American Journal of Cardiology|October 6, 2009
Mitral E wave deceleration time to peak E velocity ratio and cardiovascular outcome in hypertensive patients during antihypertensive treatment (from the LIFE echo-substudy)Marcello Chinali, Gerard P Aurigemma, Giovanni de Simone, et al.
The American Journal of Cardiology|December 28, 2004
Aortic valve sclerosis relates to cardiovascular events in patients with hypertension (a LIFE substudy)Michael H Olsen, Kristian Wachtell, Jonathan N Bella, et al.
JAMA|November 18, 2004
Prognostic significance of left ventricular mass change during treatment of hypertensionRichard B Devereux, Kristian Wachtell, Eva Gerdts, et al.
International Journal of Cardiology|March 17, 2018
Left ventricular hypertrophy offsets the sex difference in cardiovascular risk (the Campania Salute Network)Eva Gerdts, Raffaele Izzo, Costantino Mancusi, et al.
Blood Pressure|May 3, 2023
Cardiovascular organ damage in relation to hypertension status in patients with ankylosing spondylitisGyda Ullensvang, Ester Kringeland, Eirik Ikdahl, et al.
Journal of Hypertension|July 11, 2013
Systolic left ventricular function according to left ventricular concentricity and dilatation in hypertensive patients: the Losartan Intervention For Endpoint reduction in hypertension studyCasper N Bang, Eva Gerdts, Gerard P Aurigemma, et al.
Blood Pressure|February 26, 2014
Impact of isolated systolic hypertension on normalization of left ventricular structure during antihypertensive treatment (the LIFE study)Costantino Mancusi, Eva Gerdts, Giovanni De Simone, et al.
Pageof 27

Showing results (171-180 of 262) with videos related to

Sort By:
Pageof 27
Journal of Hypertension|March 27, 2003
Pulse pressure/stroke index and left ventricular geometry and function: the LIFE StudyVittorio Palmieri, Jonathan N Bella, Mary J Roman, et al.
The American Journal of Cardiology|June 1, 2011
Differences in cardiovascular risk profile between electrocardiographic hypertrophy versus strain in asymptomatic patients with aortic stenosis (from SEAS data)Anders M Greve, Eva Gerdts, Kurt Boman, et al.
Circulation. Cardiovascular Imaging|April 12, 2014
Four-group classification of left ventricular hypertrophy based on ventricular concentricity and dilatation identifies a low-risk subset of eccentric hypertrophy in hypertensive patientsCasper N Bang, Eva Gerdts, Gerard P Aurigemma, et al.
The American Journal of Cardiology|October 6, 2009
Mitral E wave deceleration time to peak E velocity ratio and cardiovascular outcome in hypertensive patients during antihypertensive treatment (from the LIFE echo-substudy)Marcello Chinali, Gerard P Aurigemma, Giovanni de Simone, et al.
The American Journal of Cardiology|December 28, 2004
Aortic valve sclerosis relates to cardiovascular events in patients with hypertension (a LIFE substudy)Michael H Olsen, Kristian Wachtell, Jonathan N Bella, et al.
JAMA|November 18, 2004
Prognostic significance of left ventricular mass change during treatment of hypertensionRichard B Devereux, Kristian Wachtell, Eva Gerdts, et al.
International Journal of Cardiology|March 17, 2018
Left ventricular hypertrophy offsets the sex difference in cardiovascular risk (the Campania Salute Network)Eva Gerdts, Raffaele Izzo, Costantino Mancusi, et al.
Blood Pressure|May 3, 2023
Cardiovascular organ damage in relation to hypertension status in patients with ankylosing spondylitisGyda Ullensvang, Ester Kringeland, Eirik Ikdahl, et al.
Journal of Hypertension|July 11, 2013
Systolic left ventricular function according to left ventricular concentricity and dilatation in hypertensive patients: the Losartan Intervention For Endpoint reduction in hypertension studyCasper N Bang, Eva Gerdts, Gerard P Aurigemma, et al.
Blood Pressure|February 26, 2014
Impact of isolated systolic hypertension on normalization of left ventricular structure during antihypertensive treatment (the LIFE study)Costantino Mancusi, Eva Gerdts, Giovanni De Simone, et al.
Pageof 27